Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L I Gordon

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Bone Marrow Transplantation|June 6, 2006
Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?J Mehta, L I Gordon, M S Tallman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with zevalin, a 90Y-labeled anti-CD20 monoclonal antibodyG A Wiseman, C A White, T E Witzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphomaT E Witzig, C A White, G A Wiseman, et al.
Cancer|December 15, 1980
Small-cell carcinoma of the lung: a five-year experience with combined modality therapyP C Hoffman, H M Golomb, J D Bitran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2007
A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphomaJ P Leonard, J W Friedberg, A Younes, et al.
Bone Marrow Transplantation|January 7, 1998
High-dose chemotherapy, autologous bone marrow or stem cell transplantation and post-transplant consolidation chemotherapy in patients with advanced breast cancerM S Tallman, A W Rademaker, L Jahnke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 20, 2007
Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphomaA M Evens, J K Altman, B B Mittal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2014
The role of body mass index in survival outcome for lymphoma patients: US intergroup experienceF Hong, T M Habermann, L I Gordon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 1, 2013
Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern eraA M Evens, S Choquet, A R Kroll-Desrosiers, et al.
Bone Marrow Transplantation|May 30, 1998
T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patientsR K Burt, A E Traynor, B Cohen, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Bone Marrow Transplantation|June 6, 2006
Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?J Mehta, L I Gordon, M S Tallman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with zevalin, a 90Y-labeled anti-CD20 monoclonal antibodyG A Wiseman, C A White, T E Witzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphomaT E Witzig, C A White, G A Wiseman, et al.
Cancer|December 15, 1980
Small-cell carcinoma of the lung: a five-year experience with combined modality therapyP C Hoffman, H M Golomb, J D Bitran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2007
A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphomaJ P Leonard, J W Friedberg, A Younes, et al.
Bone Marrow Transplantation|January 7, 1998
High-dose chemotherapy, autologous bone marrow or stem cell transplantation and post-transplant consolidation chemotherapy in patients with advanced breast cancerM S Tallman, A W Rademaker, L Jahnke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 20, 2007
Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphomaA M Evens, J K Altman, B B Mittal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2014
The role of body mass index in survival outcome for lymphoma patients: US intergroup experienceF Hong, T M Habermann, L I Gordon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 1, 2013
Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern eraA M Evens, S Choquet, A R Kroll-Desrosiers, et al.
Bone Marrow Transplantation|May 30, 1998
T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patientsR K Burt, A E Traynor, B Cohen, et al.
Pageof 8